
Bridget E. Bunner
Examiner (ID: 19030, Phone: (571)272-0881 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1644, 1647 |
| Total Applications | 1463 |
| Issued Applications | 725 |
| Pending Applications | 157 |
| Abandoned Applications | 602 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5285483
[patent_doc_number] => 20090099158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR'
[patent_app_type] => utility
[patent_app_number] => 12/039162
[patent_app_country] => US
[patent_app_date] => 2008-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27426
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20090099158.pdf
[firstpage_image] =>[orig_patent_app_number] => 12039162
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/039162 | TETRAHYDROISOQUINOLINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR | Feb 27, 2008 | Abandoned |
Array
(
[id] => 8294453
[patent_doc_number] => 08222239
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-17
[patent_title] => 'Bridged polycyclic compound based compositions for the inhibition and amelioration of disease'
[patent_app_type] => utility
[patent_app_number] => 12/035351
[patent_app_country] => US
[patent_app_date] => 2008-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 35627
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12035351
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/035351 | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease | Feb 20, 2008 | Issued |
Array
(
[id] => 92544
[patent_doc_number] => 07737272
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-15
[patent_title] => 'Diazaphosphacycle transition metal complexes'
[patent_app_type] => utility
[patent_app_number] => 12/032350
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 16
[patent_no_of_words] => 18049
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/737/07737272.pdf
[firstpage_image] =>[orig_patent_app_number] => 12032350
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/032350 | Diazaphosphacycle transition metal complexes | Feb 14, 2008 | Issued |
Array
(
[id] => 6454571
[patent_doc_number] => 20100105658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'AZA-BRIDGED-RING COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/524758
[patent_app_country] => US
[patent_app_date] => 2008-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30540
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105658.pdf
[firstpage_image] =>[orig_patent_app_number] => 12524758
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/524758 | Aza-bridged-ring compound | Feb 7, 2008 | Issued |
Array
(
[id] => 4826936
[patent_doc_number] => 20080125439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'DIAZAINDOLE-DICARBONYL-PIPERAZINYL ANTIVIRAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/026633
[patent_app_country] => US
[patent_app_date] => 2008-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35964
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20080125439.pdf
[firstpage_image] =>[orig_patent_app_number] => 12026633
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/026633 | Diazaindole-dicarbonyl-piperazinyl antiviral agents | Feb 5, 2008 | Issued |
Array
(
[id] => 9977497
[patent_doc_number] => 09023808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Macrocyclic inhibitors of hepatitis C virus'
[patent_app_type] => utility
[patent_app_number] => 11/995869
[patent_app_country] => US
[patent_app_date] => 2008-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24255
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11995869
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/995869 | Macrocyclic inhibitors of hepatitis C virus | Jan 15, 2008 | Issued |
Array
(
[id] => 6403015
[patent_doc_number] => 20100179318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-15
[patent_title] => 'PROCESS TO MAKE LESTAURTINIB'
[patent_app_type] => utility
[patent_app_number] => 12/522993
[patent_app_country] => US
[patent_app_date] => 2008-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1456
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20100179318.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522993
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522993 | PROCESS TO MAKE LESTAURTINIB | Jan 10, 2008 | Abandoned |
Array
(
[id] => 8858583
[patent_doc_number] => 08461117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-11
[patent_title] => 'Chemical linkers and cleavable substrates and conjugates thereof'
[patent_app_type] => utility
[patent_app_number] => 12/521391
[patent_app_country] => US
[patent_app_date] => 2007-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 61664
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12521391
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/521391 | Chemical linkers and cleavable substrates and conjugates thereof | Dec 27, 2007 | Issued |
Array
(
[id] => 9250441
[patent_doc_number] => 08614220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-24
[patent_title] => 'Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/520842
[patent_app_country] => US
[patent_app_date] => 2007-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37619
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12520842
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/520842 | Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors | Dec 16, 2007 | Issued |
Array
(
[id] => 4720130
[patent_doc_number] => 20080242653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Cyclopropyl amine derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/956816
[patent_app_country] => US
[patent_app_date] => 2007-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 39221
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20080242653.pdf
[firstpage_image] =>[orig_patent_app_number] => 11956816
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/956816 | Cyclopropyl amine derivatives | Dec 13, 2007 | Issued |
Array
(
[id] => 5398618
[patent_doc_number] => 20090318681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'METAL COMPLEX, AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/518396
[patent_app_country] => US
[patent_app_date] => 2007-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8655
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318681.pdf
[firstpage_image] =>[orig_patent_app_number] => 12518396
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/518396 | METAL COMPLEX, AND USE THEREOF | Dec 10, 2007 | Abandoned |
Array
(
[id] => 4432689
[patent_doc_number] => 07968708
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-28
[patent_title] => 'Azepans and methods for making and using same'
[patent_app_type] => utility
[patent_app_number] => 11/999723
[patent_app_country] => US
[patent_app_date] => 2007-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 24
[patent_no_of_words] => 8623
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/968/07968708.pdf
[firstpage_image] =>[orig_patent_app_number] => 11999723
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/999723 | Azepans and methods for making and using same | Dec 5, 2007 | Issued |
Array
(
[id] => 9140349
[patent_doc_number] => 08580810
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => 'Compounds and formulations suitable for radical scavenging'
[patent_app_type] => utility
[patent_app_number] => 12/516992
[patent_app_country] => US
[patent_app_date] => 2007-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 26830
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12516992
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/516992 | Compounds and formulations suitable for radical scavenging | Nov 28, 2007 | Issued |
Array
(
[id] => 7523090
[patent_doc_number] => 08026246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-09-27
[patent_title] => 'Aurora kinase inhibitors for inhibiting mitotic progression'
[patent_app_type] => utility
[patent_app_number] => 11/985277
[patent_app_country] => US
[patent_app_date] => 2007-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10667
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/026/08026246.pdf
[firstpage_image] =>[orig_patent_app_number] => 11985277
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/985277 | Aurora kinase inhibitors for inhibiting mitotic progression | Nov 13, 2007 | Issued |
Array
(
[id] => 4873937
[patent_doc_number] => 20080200671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Crystal form of asenapine maleate'
[patent_app_type] => utility
[patent_app_number] => 11/939023
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4529
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200671.pdf
[firstpage_image] =>[orig_patent_app_number] => 11939023
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/939023 | Crystal form of asenapine maleate | Nov 12, 2007 | Issued |
Array
(
[id] => 8802406
[patent_doc_number] => 08440680
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-14
[patent_title] => '2,6-diphenyl-4,8-diazoadamantan-1-one and derivatives thereof, process of manufacture and use for the formulation of solutions with sterilizing and disinfectant effect'
[patent_app_type] => utility
[patent_app_number] => 12/520821
[patent_app_country] => US
[patent_app_date] => 2007-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 1064
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12520821
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/520821 | 2,6-diphenyl-4,8-diazoadamantan-1-one and derivatives thereof, process of manufacture and use for the formulation of solutions with sterilizing and disinfectant effect | Nov 11, 2007 | Issued |
Array
(
[id] => 4734445
[patent_doc_number] => 20080051425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'VINORELBINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/931080
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20376
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20080051425.pdf
[firstpage_image] =>[orig_patent_app_number] => 11931080
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/931080 | VINORELBINE DERIVATIVES | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4965824
[patent_doc_number] => 20080108644
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'VINCA DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 11/933259
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38176
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108644.pdf
[firstpage_image] =>[orig_patent_app_number] => 11933259
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/933259 | Vinca derivatives | Oct 30, 2007 | Issued |
Array
(
[id] => 4765617
[patent_doc_number] => 20080176829
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'Compounds'
[patent_app_type] => utility
[patent_app_number] => 11/980114
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39041
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176829.pdf
[firstpage_image] =>[orig_patent_app_number] => 11980114
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/980114 | Tricyclic compounds, compositions, and methods useful in the treatment or prophylaxis of 5-HT6 receptor-related disorders | Oct 29, 2007 | Issued |
Array
(
[id] => 4728046
[patent_doc_number] => 20080207590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Inhibitors of Histone Deacetylase'
[patent_app_type] => utility
[patent_app_number] => 11/925151
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 107585
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207590.pdf
[firstpage_image] =>[orig_patent_app_number] => 11925151
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/925151 | Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors | Oct 25, 2007 | Issued |